Oxycarboxin

Oxycarboxin

SCHEMBL4335924

CC1=C(C(=O)Nc2ccccc2)CCCO1.CC1=C(C(=O)Nc2ccccc2)S(=O)(=O)CCO1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.46
RAB9A P51151 5/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
KMT2A Q03164 5/20 0.46
MAPT P10636 3/20 0.46
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
PKM P14618 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
XBP1 P17861 1/20 0.46
S1PR4 O95977 1/20 0.45
S1PR1 P21453 1/20 0.45
CCR6 P51684 1/20 0.45
ATM Q13315 1/20 0.45
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
DHODH Q02127 3/20 0.39
MEN1 O00255 3/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxycarboxin SCHEMBL11633226 0.91 KMT2A (0.42) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Oxycarboxin SCHEMBL28267507 0.89 RAB9A (0.56) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Oxycarboxin SCHEMBL18897 0.89 RAB9A (0.56) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL21874 0.87 MAPK1 (0.56) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Oxycarboxin SCHEMBL4175380 0.79 MAPK1 (0.76) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Oxycarboxin SCHEMBL8819774 0.79 MAPT (0.45) NPC1RAB9ASMN1; SMN2KMT2AMAPT
SCHEMBL7019511 0.79 HSD17B10 (0.58) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Oxycarboxin SCHEMBL4430072 0.78 SMN1; SMN2 (0.44) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Mepronil SCHEMBL3022839 0.74 HPGD (0.46) NPC1RAB9ASMN1; SMN2KMT2AMAPT
Oxycarboxin SCHEMBL16755351 0.72 MAPK1 (0.61) NPC1RAB9ASMN1; SMN2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1960485-A4 COMPOSITION AND PROCESS FOR COLORING WOOD OSMOSE INC (US) 2009-07-08 EP disclosed
EP-1960485-A2 COMPOSITION AND PROCESS FOR COLORING WOOD Osmose, Inc. (US) 2008-08-27 EP disclosed
WO-2007070769-A2 COMPOSITION AND PROCESS FOR COLORING WOOD OSMOSE, INC. (US) 2007-06-21 WO disclosed
US-20070131136-A1 Composition And Process For Coloring Wood OSMOSE, INC. (US) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070131136-A1 Composition And Process For Coloring Wood BTD, MGAM, CYB5R3 NPC1 2526/4885RAB9A 3576/4885SMN1; SMN2 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.